D-0166-2021 Class I Terminated
FDA drug recall D-0166-2021 was initiated by Torrent Pharma Inc on November 25, 2020 and is designated Class I. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated December 28, 2022). Affected quantity: 2496 Bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- December 9, 2020
- Initiation Date
- November 25, 2020
- Termination Date
- December 28, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2496 Bottles
Product Description
Anagrelide Capsules, USP 1 mg, 100 capsules, Rx only, Manufactured in India for: Torrent Pharma Inc., Basking Ridge, NJ 07920 NDC 13668-462-01
Reason for Recall
Failed Dissolution Specifications
Distribution Pattern
Nationwide USA and Puerto Rico
Code Information
Batch BFD1G001, exp 12/2021